|
Post by careful2invest on Oct 3, 2018 15:59:59 GMT -5
I have seen Afrezza commercials on Fox quite a bit! My TV is rarely on any other network. GLTA!!
|
|
|
Post by careful2invest on Sept 29, 2018 15:11:05 GMT -5
I bought my first Mnkd shares in 2007. I dunno, do I have a problem? Maybe. I think I might have problem. Nope, I don’t have a problem. Well, maybe...... CCI, I couldnt have said it better myself! I think most (if not all) of us are MNKDholics! How else can one be down a strong six figures and watch this company's every move daily, sometimes hourly, and still be talking about the great potential of my investment in this company, if not a mnkdholic? I too, may have a problem!! GLTA TRUE LONGS!!
|
|
|
Post by careful2invest on Sept 14, 2018 23:09:14 GMT -5
And MNKD is a cult stock. Even when you’re out you’re still in:-) The shorts are just as big of a cult. Waiting for the train wreck. Your ears at the door. You wonder, you watch, you wait. But if you’re a MNKD long.. you’ve learned that life isn’t about waiting for the storm to pass it’s about learning how to dance in the rain:-) What else can you do ..because with bad news the stock goes down, with good news the stock goes down. Nothing to do but take a break and stop watching the tape:-) Great observation/analogy/explanation/advice Sports, of what it takes to be Long MNKD!! We're definitely in it for the long haul!! Al Mann knew what he had! We knew what he had! Finally, the rest of the world is beginning to find out about it! Great things to come! GLTA LONGS!
|
|
|
Post by careful2invest on Sept 9, 2018 17:12:49 GMT -5
Falcon wrote... "The absolute essence of success for Mannkind hinges on the success of Technosphere. If the market accepts drug delivery via Technosphere then Mannkind will be unstoppable. They can ink as many deals as they want but the market must accept the product. If that happens, lookout it's game over. I'm still waiting to see that happen"
As others have mentioned, Technosphere has the potential to be substantially bigger than Afrezza, but at the same time, if/when Afrezza can become the standard of care for Diabetes, Mannkind will be as successful as Al Mann set out to make it. We are in for great returns...Patience will need to be excercised, (as it has been the case for many of us) but it appears that many components are aligning for ultimate success of Mannkind Corp! Hopefully we all live long enough to see it to fruition!! GLTA True Longs!!
It's been a long time, and the journey is far from over, but we are certainly finally headed in the right direction! I am finally buying again!
|
|
|
Post by careful2invest on Jul 6, 2018 17:45:43 GMT -5
I love you sports. In my world, FOX is political. Yes Fox is political, but we are going for the biggest ratings, we want the most people possible to learn about Afrezza:-) Saw Afrezza commercial in Ohio at about 8:00 am today in Ohio. Pleasantly surprised!! And as far as Fox being political, these days, ALL "news" networks have become political, don't you think? Fox just happens to be the most accurate in their conveyence of the events going on in our world. js GLTA!!
|
|
|
Post by careful2invest on Jun 26, 2018 20:29:39 GMT -5
And one more thing, the "8.0 to 6.8" was from the the Affinity 1 which had 518 participants which should be enough to stop the whiners about STAT only having 60 and not being big enough. clinicaltrials.gov/ct2/show/NCT01445951Bashers, and soft bashers will do what they do and say what they say no matter what facts are in front of them. We are finally on a solid path toward success with a competent and stellar team at the helm. IMHO, Whiners (bashers/shorts) opinions should be taken with a grain of salt at this point. GLTA Longs!!
|
|
|
Post by careful2invest on May 16, 2018 11:43:47 GMT -5
EDT = Exempt Drill and Training? or have I been in the military too long? OOG For the record... EDT- Eastern Daylight Time. GLTA!
|
|
|
Post by careful2invest on Apr 22, 2018 21:49:50 GMT -5
What happened is the same thing which happened with afrezza. The results were too good and the 171 design provided the industry enough to say the RAAs are better. Could you imagine if afrezza replaced the need for the RAAs in the pump? Next it would replace the RAAs for MDI T1s. If it became the standard of care for T2s they would never progress to needing the basal and sure wouldn't need the RAAs. This would kill the industry. At the afrezza ADCOM there was FDA pressure to only approve for the T2s. Still awaiting an answer from Mike or Dr. Kendall on this topic, but we all remember that Dr. Kendall used those very words in bold print, "Standard of care" when he spoke of Afrezza. We will be finding out very soon if Dr. Kendall's influence in the diabetic treatment community is strong enough to make this happen. Otherwise, we are done. Afrezza is a game changer, if they (Big Pharma) allow it be! May good prevail! GLTA!
|
|
|
Post by careful2invest on Apr 22, 2018 17:11:42 GMT -5
Good question!! Best answered by Mike Castagna, or David Kendall. Gentleman, What say you?
|
|
|
Post by careful2invest on Apr 15, 2018 14:17:35 GMT -5
Unless I'm missing something.. It's sounding and looking more and more like Mnkd needs a partner to get this all done.. I agree sweedee! That is what it's going to take to make Afrezza a success! Bottom line! GLTA!
|
|
|
Post by careful2invest on Apr 9, 2018 22:29:58 GMT -5
Great presentation over all! One, possibly two deals pending soon. That's reassuring. Possibly no more dillution.
But a couple things I wish Mike would have mentioned...(and if he did, I may have missed it) And not sure of the importance with this audience, but my thoughts anyway...
He did not say anything about how Afrezza mimicks a healthy pancreas. Nor did he emphasize how Afrezza is totally out of your system within x time. And no mention of Alfred Mann. And what a legacy!! With all that Al accomplished in his life and with Afrezza being his crown jewel, not to mention that he invested over a billion $ of his own money to make it happen That alone showed the conviction that Al had in Afrezza. That may have been a missed opportunity to gain additional respect of the product, and what it took to get it to market. But over all, very positive! GLTA!
|
|
|
Post by careful2invest on Mar 24, 2018 14:06:19 GMT -5
Al had the guts and smarts to avoid selling cheap and take the long road. However, taking the long road required settling for a sub-optimal Sanofi deal. That seems a little contradictory, but perhaps that is just me. Yep, it's just you, Here again, a true mnkdfann would get this, but a short... well maybe not so much, and may attempt to find a blemish. This is my interpretation of what radgray68 is saying... Al avoided "selling cheap" because he did NOT SELL. Al settled for a "sub-optimal Sanofi deal" which was a partnership, not a sale. Although, it appeared that Al's options were very limited when he made the ill fated agreement with Sanofi. Which in hindsight, for reasons most of us are too well aware, nearly burried the company, but currently, there is still a company (Mannkind Corp) that solely still owns Afrezza, and is not a thing of the past. Hence the mention of Al Manns "guts and smarts" And imho, Mannkind is finally now on a well orchestrated path to success. Admittedly, a lot of work ahead, but on a positive path nonetheless. In addition, I am a true MNKD Fan! GLTA, Unless you are short MNKD!
|
|
|
Post by careful2invest on Mar 1, 2018 14:38:35 GMT -5
This is a great great interview. He is going to really open doors at the scientific level for MannKind. In my opinion, this upcoming ADA meeting in June will be the most productive one ever for MannKind. I agree! Nice find kimi! GLTA!
|
|
|
Post by careful2invest on Feb 28, 2018 10:49:47 GMT -5
Dilution is the only way the company can generate significant income, enough to keep the company afloat anyway. They can't do it through sales and they can't do it through partnerships. The company has diluted shareholders consistently over the last two years and I don't expect it to stop anytime soon, as the company is nowhere near profitable and likely won't be for several more years. Investors had better get accustomed to dilution. Those new shares everyone voted for a few months ago appear to be planned for issuance by the way of secondary offerings and employee stock options. Not very beneficial for existing shareholders but again, the prospects of dilution should not be taking anyone by surprise anymore, sadly enough. Can't do it through partnerships? That is just not true! Mike has even mentioned about partnerships with money upfront. Dr. Kendall has only worked for MNKD for 12 full days. Give them some time. The tide is turning! GLTA!
|
|
|
Post by careful2invest on Feb 28, 2018 10:37:11 GMT -5
I have listened to a lot of these calls for a lot of years and IMO this was the best I have heard. I think today marks a turning point for the company. The biggest news I heard on the call was they found the 60+ studies which Al Mann did and Dr. Kendall not only read them but is putting a plan together to release them. That is huge. While he did not say it I suspect these studies had a great deal to do with why Dr. Kendall came to MNKD. Al left no stone un-turned and concluded afrezza should be the standard of care for all T2s from the first day they are diagnosed. If only I had a nickle for every turning point we've had with this company. Unfortunately, many of the previous turning points were negative, but things are different now.
|
|